Zolasta 4mg Injection

Name: Zolasta 4mg Injection
Brand: SURYA SPECIALITY PHARMA
Price: 2946 INR
Availability: InStock

Price 2946 INR/ Thousand

Get a Price/Quote

MOQ : 5 Vials

Zolasta 4mg Injection Specification

Indication
Osteoporosis, bone metastasis, hypercalcemia associated with malignancy

Dosage Form
Injection

Origin of Medicine
Allopathic

Salt Composition
Zoledronic Acid 4mg

Pacakaging (Quantity Per Box)
1 vial per box

Drug Type
Prescription medicine

Ingredients
Zoledronic Acid

Physical Form
Liquid (Injection)

Function
Bone density conservation, treatment of bone damage due to cancer

Recommended For
Treatment of bone metastases, hypercalcemia of malignancy, and osteoporosis

Dosage
4 mg per injection, as advised by physician

Dosage Guidelines
Administer as a single intravenous infusion over at least 15 minutes, dosage to be determined by healthcare professional

Suitable For
Adults

Quantity
1 vial

Storage Instructions
Store below 30°C, protect from light and moisture

ATC Code
M05BA08

Appearance
Clear, colorless to slightly yellow solution

Marketed By
Onkos

Route of Administration
Intravenous (IV) infusion

Contraindications
Hypersensitivity to zoledronic acid or other bisphosphonates, severe renal impairment

Side Effects
Fever, fatigue, bone pain, nausea, headache, hypocalcemia

Brand Name
Zolasta

Prescription Required
Yes

Caution
Monitor renal function before and during therapy, ensure adequate hydration

Shelf Life
2 years from date of manufacture

Therapeutic Class
Bisphosphonate

Regulatory Approval
Approved by CDSCO (India)

Zolasta 4mg Injection About

Experience the Grand price cut with Zolasta 4mg Injection-a hot deal from Onkos, specially developed for adults requiring advanced bone density treatment. Zolasta, an incomparable bisphosphonate, delivers enlightened therapeutic results for osteoporosis, bone metastasis, and hypercalcemia of malignancy. Each clear, colorless to slightly yellow vial contains 4mg of Zoledronic Acid for IV infusion, ensuring precise dosing under medical guidance. Find the assurance of CDSCO regulatory approval, robust two-year shelf life, and trusted market distribution throughout India. Prescription required. Protect from light and moisture; store below 30C.

Recommended Usage and Administration

Zolasta 4mg Injection is used by adults for managing bone metastases, osteoporosis, and hypercalcemia due to malignancy. The recommended direction of use involves a single intravenous infusion over at least 15 minutes, strictly under the advice and supervision of a healthcare professional. It is not suitable for those hypersensitive to zoledronic acid or with severe renal issues. Always monitor renal function and maintain adequate hydration during therapy for safer outcomes.

Sample Policy & Payment Terms at Lowest Price

At Zolasta, we provide samples and maintain a transparent policy to ensure your satisfaction and valuation of goods. Our payment terms are flexible, aiming to offer our product at the lowest price point in the market. Goods transport is handled efficiently across regions, ensuring the integrity of each vial during deliveries. For inquiries regarding samples or payment options, contact our distribution team to facilitate your requirements swiftly and securely.

FAQ's of Zolasta 4mg Injection:

Q: How is Zolasta 4mg Injection administered for optimal results?

A: Zolasta 4mg Injection should be administered as a single slow intravenous infusion over at least 15 minutes, strictly following the dosage prescribed by a healthcare professional to ensure safety and efficacy.

Q: What conditions can Zolasta 4mg Injection be used to treat?

A: Zolasta is indicated for the treatment of bone metastases, osteoporosis, and hypercalcemia associated with malignancy, helping to conserve bone density and treat bone damage caused by cancer.

Q: When should renal function be monitored during Zolasta therapy?

A: Renal function should be carefully monitored both before starting and during treatment with Zolasta to mitigate risk, especially in patients with pre-existing kidney conditions.

Q: Where should Zolasta 4mg Injection be stored for best preservation?

A: Store Zolasta below 30C, protected from light and moisture, to maintain its stability and effectiveness throughout its two-year shelf life.

Q: What are the side effects associated with Zolasta 4mg Injection usage?

A: Common side effects may include fever, fatigue, bone pain, nausea, headache, and hypocalcemia. Any unusual or severe symptoms should be promptly reported to your healthcare provider for evaluation.

Q: What is the benefit of using Zolasta 4mg Injection over other therapies?

A: Zolasta's potent bisphosphonate action offers an incomparable approach to bone density conservation and management of bone complications in cancer patients, supported by regulatory approval and established clinical use.

Tell us about your requirement